Hepatic allograft rejection under quadruple immunosuppressive regimen with cyclosporine A in liver transplantation: incidence of viral and fungal infection

Transplant Proc. 1994 Oct;26(5):2697-9.

Authors

J Fabregat¹, R Fradera, J Figueras, A Rafecas, J Torras, J Martinez LaCasa, C Baliellas, L Casais, E Jaurrieta

Affiliation

¹ Liver Transplant Unit, Universidad de Barcelona, Spain.

PMID: 7940845

No abstract available

Publication types

Clinical Trial

MeSH terms

Adolescent
Adult
Aged
Antilymphocyte Serum / therapeutic use
Cyclosporine / therapeutic use*
Cytomegalovirus Infections / diagnosis
Cytomegalovirus Infections / epidemiology*
Drug Therapy, Combination
Female
Graft Rejection / epidemiology
Graft Rejection / immunology*
Humans
Immunosuppression Therapy / methods*
Incidence
Liver Transplantation / immunology*
Male
Methylprednisolone / therapeutic use
Middle Aged
Muromonab-CD3 / therapeutic use
Mycoses / epidemiology*
Mycoses / prevention & control
Nystatin / therapeutic use
Prospective Studies
Transplantation, Homologous

Substances

Antilymphocyte Serum
Muromonab-CD3
Nystatin
Cyclosporine
Methylprednisolone